TP53 and breast cancer: Similarly, CIP2A expression was associated with high proliferation index and aneuploidy in our study on gastric cancer (Khanna et al, 2009), and in breast cancer, it was reported to associate with proliferation index, p53 mutation, and high tumour grade (Come et al, 2009).